Gilead's remdesivir hailed as COVID-19 standard of care afte...

It's official - Gilead's remdesivir helps severely ill patients recover faster from COVID-19, according to results from a phase 3 placebo-controlled trial.

Disputed COVID-19 trial failure reports send Gilead shares d...

Gilead's COVID-19 drug remdesivir seemingly failed to produce an effect according to results of a Chinese clinical trial posted inadvertently on the World Health Organizatio

Gilead shares jump after rethink of COVID-19 remdesivir tria...

Shares in Gilead were up in premarket trading after the company announced it had increased the size of its trials for its COVID-19 drug remdesivir.

Gilead slides as second Chinese trial of remdesivir is stopp...

First study of Gilead’s remdesivir in COVID-19 reveals littl...

EMA clears compassionate use of Gilead’s remdesivir for COVI...